PATENT CLAIM ANALYSIS

Application Number: 15943526
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["424", "094610"]

Abstract:
The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.

Claim (Index 28):
A method for treating mucopolysaccharidosis type 7 in a subject in need thereof, comprising administering to the subject a composition comprising a recombinant \u03b2-glucuronidase, wherein the recombinant \u03b2-glucuronidase is administered every other week by continuous intravenous infusion at a dose of 1 mg/kg to 8 mg/kg.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.05263
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15607257', '15251701', '14639171', '14849745', '13481244']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7737522460330927
- 35 USC 102 Novelty (BERT): 0.5951890841999392
- Combined Prediction Score: 0.7558959298497774
- Mean Citation Score: 478.44527200000016
- Max Citation Score: 540.85583
- Similarity Product: 458.16720468283

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test